Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Biocryst Pharmaceuticals Inc (BCRX)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Great Point Partners

Jeffrey Jay And David Kroin

7,478,275 $35,671,000 +58% 5.29%
2.
RA Capital Management

Peter Kolchinsky

6,984,692 $33,317 2.55%
3. 974,652 $4,649 -19% 2.26%
4.
Deerfield Management

James E. Flynn

7,366,460 $35,138 +3% 1.21%
5.
Baker Bros. Advisors

Julian Baker And Felix Baker

14,012,172 $66,838 +1% 0.56%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.33 45,000 Large Shareholder 12,894,240 2016-02-05 Filing
$6.65 24,800 Large Shareholder 12,849,240 2016-02-04 Filing
$6.29 91,187 Large Shareholder 12,824,440 2016-02-03 Filing
$6.52 91,728 Large Shareholder 12,733,253 2016-02-02 Filing
$6.88 25,000 Large Shareholder 12,641,525 2016-01-28 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.30 42,112 Officer 21,058 2018-06-01 Filing
$4.72 64,310 Officer 23,855 2017-11-13 Filing
$5.42 54,250 Director 119,410 2017-09-18 Filing
$9.20 3,250 Officer 141,460 2017-03-20 Filing
$9.06 3,250 Officer 117,313 2017-03-10 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 2,220,971 $10,594 2.55%
2. 154,147 $735 0.63%
3. 148,959 $711 0.34%
4. 32,500 $156 0.09%
5. 330,731 $1,578 0.04%
News See All